Denali Therapeutics Inc.

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

Source link

You May Also Like

Person looking for Virginia Rep. Gerry Connolly attacks staffers with baseball bat

A person looking for Virginia Rep. Gerry Connolly allegedly attacked two of…

UK Economy Expanded Slightly in First Quarter, Matching First Estimates

By Ed Frankl The U.K. economy grew marginally in the first quarter…

Tens of thousands protest Israeli Prime Minister Netanyahu’s proposed judicial overhaul

Tens of thousands protest Israeli Prime Minister Netanyahu’s proposed judicial overhaul –…

“These people look pathetic”: Nancy Pelosi weighs in on Trump pulling McCarthy’s strings

During a segment of CNN’s “State of the Union” on Sunday, Nancy Pelosi weighed…